4.7 Article

Overexpression of CD151 as an Adverse Marker for Intrahepatic Cholangiocarcinoma Patients

Related references

Note: Only part of the references are listed.
Article Oncology

Intrahepatic cholangiocarcinoma: report of 272 patients compared with 5,829 patients with hepatocellular carcinoma

Xin-Da Zhou et al.

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2009)

Review Oncology

Tetraspanins: push and pull in suppressing and promoting metastasis

Margot Zoeller

NATURE REVIEWS CANCER (2009)

Article Oncology

Identification of side population cells in human hepatocellular carcinoma cell lines with stepwise metastatic potentials

Guo-Ming Shi et al.

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2008)

Editorial Material Oncology

Design and endpoints of clinical trials in hepatocellular carcinoma

Josep M. Llovet et al.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2008)

Review Biotechnology & Applied Microbiology

Targeting of tetraspanin proteins - potential benefits and strategies

Martin E. Hemler

NATURE REVIEWS DRUG DISCOVERY (2008)

Article Pathology

Pitfalls in the classification of liver tumors

C. Wittekind

PATHOLOGE (2006)

Article Biochemistry & Molecular Biology

CD151 forms a functional complex with c-Met in human salivary gland cancer cells

SK Klosek et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)

Review Cell Biology

Tetraspanin functions and associated microdomains

ME Hemler

NATURE REVIEWS MOLECULAR CELL BIOLOGY (2005)

Article Oncology

Global cancer statistics, 2002

DM Parkin et al.

CA-A CANCER JOURNAL FOR CLINICIANS (2005)

Article Multidisciplinary Sciences

Potentiation of the ligand-binding activity of integrin α3β1 via association with tetraspanin CD151

R Nishiuchi et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)

Review Cell Biology

Specific tetraspanin functions

ME Hemler

JOURNAL OF CELL BIOLOGY (2001)

Article Neurosciences

Tetraspan protein CD151: A common target of mood stabilizing drugs?

LV Hua et al.

NEUROPSYCHOPHARMACOLOGY (2001)